We aim to ensure relevant, accurate and timely information is available to our investors and the rest of the financial community. Genmab's ordinary shares are listed on the Nasdaq Copenhagen and American Depository Shares issued under its ADR Program are listed on the Nasdaq Global Select Market in the United States.
As part of our Investor Relations activities we:
- Observe quiet periods before issuing financial reports
- Issue announcements about relevant news and developments regarding our company and our products, technologies and partnerships
- Hold regular analyst and investor meetings to discuss our financial reports or other important news events
- Provide financial guidance for the year
- Maintain an updated website which includes corporate documents, financial reports, stock information and other information on the company, including our products and technology
- Have a dedicated IR contact person.